Clinical Trial Update: A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial evaluating a recombinant anti-IL-1β monoclonal antibody in Chinese participants with acute gout is in early-phase stages with statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• recombinant anti-IL-1β humanized monoclonal antibody (anti-IL-1β monoclonal antibody)

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Acute Gout | Phase 1, Phase 2 | Status: UNKNOWN